Liabilities Related to Future Royalties and Milestones, Net - Schedule of Changes Related to Future Royalties and Milestones (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Liability, Future Revenue, Rollforward [Abstract] | ||
| Beginning balance | $ 248,100 | $ 170,899 |
| Initial recognition of BioNTech liability | 38,335 | |
| Interest expense accrued on liabilities related to future royalties and milestones, net | 30,000 | |
| Interest expense accrued on liabilities related to future royalties and milestones, net | 42,138 | 39,510 |
| Cumulative catch-up adjustment | (5,699) | (30,644) |
| Revenue share payments | (4,339) | |
| Ending balance | 280,200 | 248,100 |
| Liability, Future Revenue [Abstract] | ||
| Current portion of liabilities related to future royalties and milestones, net | 10,000 | 3,500 |
| Non-current portion of liabilities related to future royalties and milestones, net | 270,200 | 244,600 |
| Total Liabilities Related to Future Royalties and Milestones, Net | $ 280,200 | $ 248,100 |